Skip to main content
Smart Investors Daily
EU

NASDAQ · EUDAW

EUDA Health Holdings Limited

Healthcare · Medical - Healthcare Information Services

$0.02

Down-$0.01 (-32.08%)

Updated Nov 5, 2026, 11:20 PM

SID Score

2.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
3.69M
P/E ratio
306.55
Dividend yield
0.00%
52-week range
$0.01 – $0.30
Volume
6.94K
Avg. volume
6.38K

Price performance · EUDAW

EUDAW price history

1M range · 5 trading sessions · Daily adjusted prices

Prices through Oct 26, 2026

EUDAW closed at $0.02 after 5 trading sessions, down 3.61% for the selected period.

Last close
$0.02
Period change
-3.61%
Period low
$0.02
Period high
$0.03
Daily close
View OHLC price history
EUDAW OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 26, 2026$0.0257$0.0257$0.0151$0.0246.94K
Oct 23, 2026$0.0241$0.0258$0.0241$0.0258910
Oct 15, 2026$0.0257$0.0257$0.0257$0.0257912
Oct 13, 2026$0.0225$0.0225$0.0225$0.0225254.48
Oct 12, 2026$0.0249$0.0249$0.0249$0.0249121.09

Latest EUDAW news

The latest Smart Investors Daily articles mentioning EUDAW.

EUDAW research

Overview

Company profile and research snapshot.

Company profile

EUDA Health Holdings Ltd is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China. It offers inventive, accessible, and science-based health solutions to support the shift in regional healthcare from reactive medical treatment to proactive, longevity-focused care. The group also runs a Singapore-based property management business. It operates in two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include management and security services for properties such as condominiums, residential apartments, business office buildings, and shopping malls.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jul 30, 2026

EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products

SINGAPORE, July 30, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and services in Asia, with a focus on Singapore, Malaysia and China, today provided important additional details of the integrated cell therapy program to be pursued under its recently announced non-binding Memorandum of Understanding (MOU) with GO POSB Organoids Pte Ltd (“GO POSB”) and Shenzhen Innovation Imm

Yahoo · Jul 28, 2026

EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies

SINGAPORE, July 28, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and services in Asia, with a focus on Singapore, Malaysia and China, today announced that it has signed a Memorandum of Understanding (“MOU”) with GO POSB Organoids Pte Ltd (“GO POSB”) and Shenzhen Innovation Immunotechnology Co., Ltd. (“SIIT”) to establish a tri-party collaboration with next-generation therap

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.